Evidence map›Paper›PMID 28271544›Full record

ArticleJournal of labelled compounds & radiopharmaceuticals2017

Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples.

Christopher Dietz, Robert B Clark, Frank C Nichols, Michael B Smith

Abstract read
In one paragraph

Article in Journal of labelled compounds & radiopharmaceuticals, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christopher DietzDepartment of Chemistry, The University of Connecticut, Storrs, CT, USA.
Robert B ClarkDepartment of Immunology, The University of Connecticut Health Center, Farmington, CT, USA.
Frank C NicholsDivision of Periodontology, The University of Connecticut Health Center, Farmington, CT, USA.
Michael B SmithDepartment of Chemistry, The University of Connecticut, Storrs, CT, USA.ORCID 0000-0002-8436-4471
UConn Health · USUniversity of Connecticut · US

Funding

Porphyromonas gingivalis lipids mediate bone loss through TLR2R01DE021055 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI NICHOLS, FRANK C · 2011 to 2015
$1.9M
Porphyromonas gingivalis glycine lipids mediate bone loss through TLR2R01DE027642 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI NICHOLS, FRANK C · 2019 to 2022
$1.6M
Porphyromonas gingivalis lipids mediate bone loss through TLR2R56DE021055 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI NICHOLS, FRANK C · 2017 to 2017
$359k
NIDCR NIH HHS R01 DE021055NIDCR NIH HHS R01 DE027642NIDCR NIH HHS R56 DE021055
6 · The paper itself

Abstract

Bacterial serine dipeptide lipids are known to promote inflammatory processes and are detected in human tissues associated with periodontal disease or atherosclerosis. Accurate quantification of bacterial serine lipid, specifically lipid 654 [((S)-15-methyl-3-((13-methyltetradecanoyl)oxy)hexadecanoyl)glycyl-l-serine, (3S)-l-serine] isolated from Porphyromonas gingivalis, in biological samples requires the preparation of a stable isotope internal standard for sample supplementation and subsequent mass spectrometric analysis. This report describes the convergent synthesis of a deuterium-substituted serine dipeptide lipid, which is an isotopically labeled homologue that represents a dominant form of serine dipeptide lipid recovered in bacteria.

Indexed as

Lipid MetabolismChemistry Techniques, SyntheticDeuteriumDipeptidesIsotope LabelingLipidsLipopeptidesPorphyromonas gingivalisSerineStereoisomerismVirulence FactorsDeuteriumDipeptidesLipidsLipopeptidesSerineserine dipeptide lipid 654Virulence Factorsbacteriaddipeptideslipidsperidontal diseasesynthesis

Identifiers

PMID28271544
PMCPMC5500292
OpenAlexW2592444795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.